BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 20060354)

  • 1. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
    Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
    Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
    Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
    Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
    Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
    Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
    Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
    Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
    Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
    Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
    Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of methylation patterns of cancer genes in salivary gland tumors.
    Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
    Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
    Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between FHIT and WWOX expression and clinicopathological features in hepatocellular carcinoma].
    Lin J; Wang B; Huang AM; Wang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):357-60. PubMed ID: 20510001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma.
    Rutherford S; Yu Y; Rumpel CA; Frierson HF; Moskaluk CA
    Cancer Lett; 2006 May; 236(2):309-17. PubMed ID: 16054751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
    Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.